Cargando…

Blood Eosinophil Count and Hospital Readmission in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease

PURPOSE: This retrospective, observational cohort study investigated the association of blood eosinophil counts within 1 week of hospitalization for acute exacerbation of COPD (AECOPD) with subsequent risk of all-cause and COPD-related readmission from a large integrated health system. PATIENTS AND...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hegewald, Matthew J, Horne, Benjamin D, Trudo, Frank, Kreindler, James L, Chung, Yen, Rea, Susan, Blagev, Denitza P
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7591040/ https://www.ncbi.nlm.nih.gov/pubmed/33122901 http://dx.doi.org/10.2147/COPD.S251115

Ejemplares similares

The Summit Score Stratifies Mortality and Morbidity in Chronic Obstructive Pulmonary Disease
por: Horne, Benjamin D, et al.
Publicado: (2020)

Better with Time: Reductions in Mortality in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease
por: Blagev, Denitza P.
Publicado: (2020)

The Laboratory-Based Intermountain Validated Exacerbation (LIVE) Score Identifies Chronic Obstructive Pulmonary Disease Patients at High Mortality Risk
por: Blagev, Denitza P., et al.
Publicado: (2018)

Laboratory-based Intermountain Validated Exacerbation (LIVE) Score stability in patients with chronic obstructive pulmonary disease
por: Blagev, Denitza P, et al.
Publicado: (2020)

Variability of Blood Eosinophil Count at Stable-State in Predicting Exacerbation Risk of Chronic Obstructive Pulmonary Disease
por: Kwok, Wang Chun, et al.
Publicado: (2023)

Blood Eosinophil Counts in Clinical Trials for Chronic Obstructive Pulmonary Disease
por: Singh, Dave, et al.
Publicado: (2020)

Blood Eosinophil Count as a Predictive Biomarker of Chronic Obstructive Pulmonary Disease Exacerbation in a Real-World Setting
por: Komura, Moegi, et al.
Publicado: (2023)

Blood eosinophil count predicts treatment failure and hospital readmission for COPD
por: Kerkhof, Marjan, et al.
Publicado: (2020)

Variability of blood eosinophil count and prognosis of COPD exacerbations
por: Martínez-Gestoso, Sandra, et al.
Publicado: (2021)

Association between blood eosinophil count and bacterial infection and clinical outcomes in patients with severe exacerbations of chronic obstructive pulmonary disease
por: Wang, Fei, et al.
Publicado: (2022)

Effect of inhaled corticosteroids on blood eosinophil count in steroid-naïve patients with COPD
por: Kreindler, James L, et al.
Publicado: (2016)

Association of Upon-Diagnosis Blood Eosinophilic Count with Frequency and Severity of Annual Exacerbation in Chronic Obstructive Pulmonary Disease: A Prospective Longitudinal Analysis
por: Kiani, Arda, et al.
Publicado: (2023)

Blood Count of Eosinophil Polymorphonuclear Leucocytes and Bronchial Hyperreactivity in Chronic Obstructive Pulmonary Disease
por: Cukic, Vesna
Publicado: (2017)

Factors Influencing the Stability of Blood Eosinophils Counts in Chronic Obstructive Pulmonary Disease Patients
por: Cai, Cheng-Sen, et al.
Publicado: (2022)

High Blood Eosinophil and YKL-40 Levels, as Well as Low CXCL9 Levels, are Associated with Increased Readmission in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease
por: Peng, Junnan, et al.
Publicado: (2021)

Blood eosinophil count-guided corticosteroid therapy and as a prognostic biomarker of exacerbations of chronic obstructive pulmonary disease: a systematic review and meta-analysis
por: Liu, Tao, et al.
Publicado: (2021)

Association between blood eosinophil count and risk of readmission for patients with asthma: Historical cohort study
por: Kerkhof, Marjan, et al.
Publicado: (2018)

Risk factors for early readmission after acute exacerbation of chronic obstructive pulmonary disease
por: Jo, Yong Suk, et al.
Publicado: (2020)

Peripheral Blood Eosinophil as a Biomarker in Outcomes of Acute Exacerbation of Chronic Obstructive Pulmonary Disease
por: Wu, Hong-Xia, et al.
Publicado: (2019)

Blood Eosinophil Counts in Chronic Obstructive Pulmonary Disease: A Biomarker of Inhaled Corticosteroid Effects
por: Singh, Dave
Publicado: (2020)

Autopsy insights from the EVALI epidemic
por: Blagev, Denitza P, et al.
Publicado: (2020)

Richness of sputum microbiome in acute exacerbations of eosinophilic chronic obstructive pulmonary disease
por: Qi, Yu-Jing, et al.
Publicado: (2020)

Greater eosinophil counts at first COPD hospitalization are associated with more readmissions and fewer deaths
por: Li, Qing, et al.
Publicado: (2019)

The association between blood eosinophil percent and bacterial infection in acute exacerbation of chronic obstructive pulmonary disease
por: Choi, Juwhan, et al.
Publicado: (2019)

Blood Eosinophil and Risk of Exacerbation in Chronic Obstructive Pulmonary Disease Patients: A Retrospective Cohort Analysis
por: Chan, Ming Chiu, et al.
Publicado: (2020)

Emergency department management of acute exacerbations of chronic obstructive pulmonary disease: factors predicting readmission
por: Bartels, Wiebke, et al.
Publicado: (2018)

Early readmission and mortality in acute exacerbation of chronic obstructive pulmonary disease with community-acquired pneumonia
por: Shin, Beomsu, et al.
Publicado: (2018)

Using Blood Eosinophil Count as a Biomarker to Guide Corticosteroid Treatment for Chronic Obstructive Pulmonary Disease
por: Sivapalan, Pradeesh, et al.
Publicado: (2021)

High suPAR and Low Blood Eosinophil Count are Risk Factors for Hospital Readmission and Mortality in Patients with COPD
por: Håkansson, Kjell E J, et al.
Publicado: (2020)

Concerns About Coronavirus Disease–Related Collateral Damage for Patients With COPD
por: Press, Valerie G., et al.
Publicado: (2020)

Elevated Peripheral Blood Eosinophils during Acute Exacerbation of Chronic Obstructive Pulmonary Disease: Prevalence and clinical significance
por: Al Sibani, Maitha, et al.
Publicado: (2022)

Relationship of Blood Eosinophils with Fractional Exhaled Nitric Oxide and Pulmonary Function Parameters in Chronic Obstructive Pulmonary Disease (COPD) Exacerbation
por: Tang, Bin, et al.
Publicado: (2020)

Time to Revisit the Hospital Readmissions Reduction Program for Patients Hospitalized for Chronic Obstructive Pulmonary Disease Exacerbations
por: LaBedz, Stephanie L., et al.
Publicado: (2021)

Differences in the lipid metabolism profile and clinical characteristics between eosinophilic and non-eosinophilic acute exacerbation of chronic obstructive pulmonary disease
por: Wang, Yating, et al.
Publicado: (2023)

Exacerbations and health care resource use among patients with COPD in relation to blood eosinophil counts
por: Müllerová, Hana, et al.
Publicado: (2019)

Re: Elevated Peripheral Blood Eosinophils during Acute Exacerbation of Chronic Obstructive Pulmonary Disease: Prevalence and clinical significance
por: Okauchi, Shinichiro, et al.
Publicado: (2022)

Blood Eosinophils and Clinical Outcomes in Inpatients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease: A Prospective Cohort Study
por: Pu, Jiaqi, et al.
Publicado: (2023)

Pulmonary Rehabilitation after a Chronic Obstructive Pulmonary Disease Exacerbation: Impact on Readmission Risk in a Real-World Setting
por: Nici, Linda
Publicado: (2021)

Using Machine Learning to Predict Likelihood and Cause of Readmission After Hospitalization for Chronic Obstructive Pulmonary Disease Exacerbation
por: Bonomo, Matthew, et al.
Publicado: (2022)

Association of elevated fractional exhaled nitric oxide concentration and blood eosinophil count with severe asthma exacerbations
por: Price, David B., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_517l2fr0k124io30ikb75cnqgi